Zoetis Inc (MIL:1ZTS)
€ 161.38 -6.8 (-4.07%) Market Cap: 72.72 Bil Enterprise Value: 77.36 Bil PE Ratio: 34.28 PB Ratio: 15.16 GF Score: 74/100

Zoetis Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 09:30PM GMT
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Zoetis today. From the company, we have Kristin Peck, the CEO; as well as Wetteny Joseph, who's going to join us for some of the Q&A after the presentation. As a reminder, we've moved away from the formal breakout sessions at the conference this year. So post the presentation, we're going to do some Q&A from the stage.

And with that, I'm going to turn it over to Kristin. Happy New Year, and thanks for joining us.

Kristin C. Peck
Zoetis Inc. - CEO & Director

All right. Well, it is great to be back. Thank you very much, Chris, especially to be back in person and to see so many familiar faces. Before we get into the real front of the day, we got some legal housekeeping. So why don't I kick into that for a second.

As you can probably imagine, we're going to have some forward-looking statements today as well as financials that are non-GAAP. The

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot